MK-4031-336

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-4031-336, covering 2014-06-12 to 2014-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)